Close Menu

Cities Bet on Biotech

States are spending a lot of money to woo biotech companies to their cities, despite the long odds, says the New York Times. The North Carolina Research Campus, also called the Biopolis, cost $500 million; Florida, particularly Palm Beach County, has spent $510 million to entice research institutes to head there (and Scripps and Torrey Pines did); and New York City is putting $45 million into science infrastructure.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.